ASTRAZENECA PLC

MarketScreener Strategies AstraZeneca PLC Nasdaq Stockholm

Stocks

AZN

GB0009895292

Pharmaceuticals

Market Closed - Nasdaq Stockholm 12:00:00 2026-10-01 EDT			5-day change	1st Jan Change
1,599.00 ^SEK	-2.11%		-2.47%	-6.13%

09-30	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
09-30	Major drugmakers turn to China for licensing deals	RE

MarketScreener Strategies

	Two favorable EU opinions for AstraZeneca	September 21, 2026 at 05:06 am
	AstraZeneca: Share price weakness of late, should be capitalised on	September 04, 2026 at 08:13 am
	AstraZeneca: BMS acquisition idea holds more red flags than green for AstraZeneca	August 03, 2026 at 08:17 am
	Heading for a major healthcare merger between AstraZeneca and Bristol-Myers Squibb?	August 03, 2026 at 06:14 am
	AstraZeneca and Bristol Myers Squibb reportedly in talks over a near $400bn merger	August 03, 2026 at 12:16 am
	AstraZeneca: In line Q2; correction of late is an entry point	July 27, 2026 at 11:12 am
	Berenberg Sticks With Its Confidence in AstraZeneca, But Lowers Its Target	July 13, 2026 at 04:54 am
	AstraZeneca: An unexpected late-stage failure doesn't derail Astra	July 10, 2026 at 07:18 am
	AstraZeneca shares slump after clinical trial fails	July 09, 2026 at 04:30 am
	AstraZeneca tumbles, Schott Pharma raises its ambitions	July 09, 2026 at 03:44 am
	The failure of a clinical trial sends AstraZeneca shares tumbling	July 09, 2026 at 03:37 am
	AstraZeneca: Desirable start to 2026, but most strengths are already priced in	April 29, 2026 at 09:18 am
	AstraZeneca: Strengths remain aptly valued	March 06, 2026 at 12:58 pm
	AstraZeneca: Bright 2026 outlook a key takeaway	February 10, 2026 at 12:01 pm
	AstraZeneca benefits from oncology momentum but valuation limits upside	November 19, 2025 at 07:43 am
	AstraZeneca delivers Q3 earnings beat but upside looks limited	November 06, 2025 at 10:14 am
	AstraZeneca's CEO reportedly considers listing in the United States	July 02, 2025 at 03:39 am

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Two favorable EU opinions for AstraZeneca

Two favorable EU opinions for AstraZeneca

September 21, 2026 at 05:06 am

AstraZeneca: Share price weakness of late, should be capitalised on

September 04, 2026 at 08:13 am

AstraZeneca: Share price weakness of late, should be capitalised on

AstraZeneca Is Said to Have Explored Bristol Myers Merger

August 05, 2026 at 03:00 pm

AstraZeneca Is Said to Have Explored Bristol Myers Merger

The best tools reserved for subscribers to boost the performance of your investments!